Aranthan Jones Ii is Chief Corp. Affairs Officer of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 81,980 shares of VNDA, which is worth approximately $376,288. The most recent transaction as insider was on Sep 15, 2021, when has been sold 16,824 shares (Common Stock) at a price of $16.49 per share, resulting in proceeds of $277,428. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 82K
0% 3M change
0% 12M change
Total Value Held $376,288

Aranthan Jones II Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2021
SELL
Open market or private sale
$277,428 $16.49 p/Share
16,824 Reduced 17.03%
81,980 Common Stock
Sep 15 2021
BUY
Exercise of conversion of derivative security
$143,004 $11.8 p/Share
12,119 Added 10.93%
98,804 Common Stock
Jul 26 2021
SELL
Open market or private sale
$142,753 $19.69 p/Share
7,250 Reduced 7.72%
86,685 Common Stock
Mar 15 2021
SELL
Open market or private sale
$318,960 $17.72 p/Share
18,000 Reduced 16.08%
93,935 Common Stock
Mar 15 2021
BUY
Exercise of conversion of derivative security
$169,800 $11.32 p/Share
15,000 Added 11.82%
111,935 Common Stock
Mar 02 2021
SELL
Open market or private sale
$69,725 $18.04 p/Share
3,865 Reduced 3.83%
96,935 Common Stock
Feb 24 2021
SELL
Open market or private sale
$459,950 $20.01 p/Share
22,986 Reduced 18.57%
100,800 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
25,800 Added 20.3%
101,287 Common Stock
Feb 24 2021
BUY
Exercise of conversion of derivative security
$276,063 $12.27 p/Share
22,499 Added 15.38%
123,786 Common Stock
AJI

Aranthan Jones Ii

Chief Corp. Affairs Officer
Washington, DC

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA